Open an Account
search icon
1
NOTIFICATIONS
Best Algo trading app in India
Bigul

Thyrocare Technologies Ltd - 539871 - Compliances- Compliance Certificate Under Regulation 7 (3) For The Period Ended September 30, 2020.

 As per the requirement of Regulation 7 (3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby confirm that activities in relation to both physical and electronic share transfer facility were maintained during the period April 1, 2020 to September 30, 2020 (both days inclusive) by the Company's Registrar and Share Transfer Agents, viz., Link Intime India Private Limited, who are registered as Registrar & Share Transfer Agent in Category-I with the Securities and Exchange Board of India vide Registration Number : INR000004058.
14-10-2020
Bigul

Thyrocare Technologies Ltd - 539871 - Statement Of Investor Complaints For The Quarter Ended September 2020

 No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Ramjee DoraiDesignation :- Company Secretary and Compliance Officer
13-10-2020
Bigul

Thyrocare Technologies Ltd - 539871 - Clarification

 With reference to significant movement in price, in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded, Thyrocare Technologies Ltd has submitted to BSE a copy of Clarification is enclosed.
09-10-2020
Bigul

Thyrocare Technologies Ltd - 539871 - Clarification sought from Thyrocare Technologies Ltd

 The Exchange has sought clarification from Thyrocare Technologies Ltd on October 9, 2020 with reference to significant movement in price, in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded.The reply is awaited.
09-10-2020
Bigul

Healthy returns for diagnostic players as business recovers

 Sharp rise in non-Covid business and strong revenue growth indicated by Thyrocare, Metropolis prop up sentiment
07-10-2020
Bigul

Thyrocare surges 15% on healthy revenue growth in September quarter

 The stock of healthcare services provider has now surpassed its previous high of Rs 845.25 touched on August 17, 2020
06-10-2020
Bigul

Thyrocare Technologies Ltd - 539871 - Announcement Under Reg. 30 Of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015.

 We have done more than 4.00 Lakh COVID-19 RT-PCR tests and more than 3.20 Lakh COVID antibody tests as on 30.09.2020. While we have enhanced the capacity to do 400 RT-PCR tests, per hour, we have got approvals for new facility at Gurgaon, Delhi by NABL. It is also built with an ability to do 400 tests per hour. We are also creating facilities for COVID testing in Bangalore and Kolkata, to meet the expected demand. Q2 of FY 21 has seen a motivating numbers and increased turnover of COVID PCR and COVID Antibody testing, and the revenue for Sept. 2020 quarter, has increased by 37% compared to Q2 of FY 20. The low revenue in Q1 of FY 21 has bounced back in Q2 of FY 21 with a growth of 171% over previous quarter. The financial statements Sept. 2020 quarter are under review by our statutory auditors and we will file our financial release post approval by Audit Committee and Board. Meanwhile, we are filing this update to keep the shareholders / stakeholders informed of the business status.
06-10-2020
Bigul

Thyrocare Technologies Ltd - 539871 - Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)

 Thyrocare Technologies Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here
01-10-2020
Bigul

Thyrocare Technologies Ltd - 539871 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report

 As already reported, the 20th Annual General Meeting ('AGM') of the Company was held on September 29, 2020 at 3.00 p.m. through Video Conferencing (VC) / Other Audio Visual Means (OAVM). In this regard, please find enclosed the following: 1. Voting results in the specified format, as required under Regulation 44 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015; 2. Report of Scrutinizer dated September 30, 2020, pursuant to Section 108 of Companies Act, 2013 ('Act'), Rule 20 (4) (xii) of the Companies (Management and Administration) Rules 2014; The above details are uploaded on the Company's website (www.thyrocare.com). Kindly take the same on your record.
30-09-2020
Bigul

Thyrocare Technologies Ltd - 539871 - Closure of Trading Window

 This is to inform you that pursuant to the provisions of SEBI (Prohibition of Insider Trading) Regulations 2015, as amended, and in accordance with the Company's Code relating to prohibition of insider trading, the trading window of the Company will remain closed for trading in Company's equity shares for Directors / Designated Employees / Connected Persons covered by the said Code, with effect from October 01, 2020, and would be re-opened after 48 hours of date of announcement / declaration of Unaudited Financial Results for the Quarter and half year ended September 30, 2020. We request you to please take the same on record.
30-09-2020
Next Page
Close

Let's Open Free Demat Account